Cronopen

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cronopen

Understanding Cronopen

Cronopen is a pharmaceutical formulation that combines two active components: amoxicillin and clavulanic acid. It belongs to a class of medications known as combination antibiotics. This medication is primarily utilized to treat a variety of bacterial infections by addressing the mechanisms that bacteria use to resist treatment.

Composition and Mechanism

The effectiveness of Cronopen is derived from the synergistic action of its two primary ingredients:

  • Amoxicillin: A broad-spectrum antibiotic from the penicillin family. It works by interfering with the ability of bacteria to form stable cell walls, which is essential for their survival.
  • Clavulanic Acid: While not an antibiotic itself, this component is a beta-lactamase inhibitor. Some bacteria produce enzymes called beta-lactamases that can break down amoxicillin before it can work. Clavulanic acid blocks these enzymes, allowing the amoxicillin to remain effective against otherwise resistant bacterial strains.

Clinical Applications

Cronopen is used to manage infections caused by susceptible bacteria in different parts of the body. Because it can overcome certain types of antibiotic resistance, it is often selected for infections where standard penicillins might not be effective. Common areas of application include:

  • Respiratory Tract Infections: Including conditions affecting the sinuses, throat, and bronchial tubes.
  • Urinary Tract Infections: Addressing bacterial growth within the bladder or kidneys.
  • Skin and Soft Tissue Infections: Managing bacterial complications resulting from wounds or localized skin conditions.
  • Otitis Media: Treating infections of the middle ear.

By combining a potent antibiotic with a protective agent, Cronopen provides a broader range of activity against various pathogens compared to amoxicillin used alone.

Regulatory References

  1. MedlinePlus - NIH

What side effects are possible with Cronopen?

Possible side effects and safety information

The safety profile of Cronopen (Azithromycin) is defined by officially documented adverse reactions and specific regulatory warnings, classified by frequency and body system involved. The information is consistent with regulatory documents published by government health authorities.


Frequency of Commonly Reported Adverse Reactions

The most commonly reported adverse reactions documented in clinical trials generally involve the gastrointestinal system. These effects are classified as Common and typically include diarrhea (sometimes loose stools), nausea, abdominal pain, and vomiting. Less commonly reported reactions, typically occurring in 1% or less of patients, include effects on the nervous system like dizziness and headache, as well as general effects like fatigue and dermatological effects such as rash.


Serious Adverse Reactions and Safety Concerns

The official labeling designates several serious adverse reactions, which, while less frequent, are critical safety warnings:

  • Cardiovascular Risks: Azithromycin is associated with QT interval prolongation on the electrocardiogram, which can lead to a potentially fatal irregular heart rhythm known as Torsades de pointes. An increased short-term risk of acute cardiovascular death has been documented, noted to be greater during the first five days of treatment.
  • Hepatotoxicity: Cases of severe, sometimes fatal, liver damage, including hepatic necrosis and hepatic failure, have been reported.
  • Hypersensitivity and Skin Reactions: Serious allergic reactions, including Anaphylaxis and severe dermatologic conditions such as Stevens-Johnson Syndrome (SJS) and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), are listed warnings.
  • Neuromuscular Effects: Exacerbation of symptoms of Myasthenia Gravis has been documented.

Safety Considerations for Specific Populations

Specific patient populations require particular attention according to regulatory guidance:

  • Hepatic and Renal Impairment: Caution is necessary in patients with significant hepatic disease. Systemic exposure is increased in those with severe renal impairment (GFR <10 mL/min).
  • Neonates: Use in infants up to 42 days of life has been linked to reports of Infantile Hypertrophic Pyloric Stenosis (IHPS).

Cronopen is contraindicated in patients with a history of hypersensitivity to Azithromycin or any macrolide/ketolide drug, or a history of cholestatic jaundice associated with prior Azithromycin use.

Overdose and Emergency Response

Official Regulatory Information on Cronopen Overdose

Regulatory documents define Cronopen overdose by focusing on severe clinical manifestations and required emergency procedures.

Domain Documented Manifestation or Action
Primary Symptoms Severe nausea, vomiting, diarrhea, and stomach discomfort are the primary documented signs of overdose. Reversible loss of hearing is also a documented macrolide overdose manifestation.
Severe Risks The life-threatening outcome associated with overdose is cardiotoxicity, specifically the potential for Prolongation of the QT interval and subsequent severe Cardiac Arrhythmia, such as Torsades de pointes.
Emergency Action Urgent medical help must be sought immediately. Individuals must call the poison control helpline, or emergency services if there is collapse, trouble breathing, seizure, or signs of cardiac distress like an irregular heartbeat, dizziness, or fainting.

Overdose Management and Monitoring

Management Approach: No specific antidote is known for Cronopen overdose. Official procedures stipulate that management must be symptomatic and supportive, aimed at maintaining vital functions. This approach may include the use of medicinal charcoal. Continuous monitoring of cardiac function is warranted due to the documented risk of severe arrhythmias.

Population Consideration: For neonates and infants up to 42 days old, official labeling advises caregivers to contact a physician immediately if the infant experiences vomiting or irritability while feeding, as this may indicate a serious toxicity complication.

Therapeutic Uses of Cronopen

What Cronopen Treats: Main Uses and Benefits

Cronopen is commonly used to help address symptom clusters that may become intense or disruptive, associated with bacterial infections in the lungs, sinuses, throat, or ears. This medicine is considered relevant for easing symptoms in acute conditions, such as pneumonia, bronchitis, otitis media, and sinusitis, as well as specific sexually transmitted infections and uncomplicated skin infections. It is applied in clinical settings that involve acute or unstable symptom patterns to provide support that helps ease the symptom load.

The medication is also relevant in managing symptoms for chronic conditions like COPD and bronchiectasis. It may be part of symptomatic management, used for managing symptoms that become more noticeable during flare-ups associated with recurrent chest infections.

“It provides support that helps ease the symptom load and supports improved comfort during periods of heightened symptoms.”


Quick Fact: Supports Management of Symptoms Related to Severe Cough and Fever


Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

The eligibility for Cronopen (Azithromycin) is determined by regulatory agencies based on age, pre-existing conditions, and organ function, with use being strictly prohibited in certain patient groups.

Classification Population Rule (Official Labeling)
Contraindicated Patients with known hypersensitivity to Azithromycin, any macrolide, or ketolide antibiotic.
Individuals with a history of cholestatic jaundice or hepatic dysfunction previously associated with Azithromycin use.
Conditional Use Patients with severe hepatic impairment (Child-Pugh Class C) are generally excluded due to insufficient data.
Use requires caution in patients with severe renal impairment (GFR < 10 mL/min) or Myasthenia Gravis.
Caution is mandatory for those with QT prolongation or other proarrhythmic conditions, including hypokalaemia.
Age Eligibility Adults and adolescents weighing ge 45 kg are eligible.
Pediatric use is not established in infants under 6 months of age.
Use in neonates (le 42 days of life) has been associated with reports of Infantile Hypertrophic Pyloric Stenosis (IHPS).
Pregnancy Status May be used during pregnancy only if clearly needed.

Cronopen is not generally recommended for patients with pneumonia who are deemed inappropriate for oral therapy due to the severity of their illness or risk factors, such as known or suspected bacteremia.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Cronopen (Azithromycin) is largely defined by pharmacodynamic effects and transport-mediated changes in drug levels, rather than significant metabolic alterations. Regulatory documents confirm that the medicine does not significantly inhibit or induce the CYP3A4 enzyme system.

Interaction Restrictions

  • Formal Contraindication: Co-administration with Ergot Derivatives (e.g., Ergotamine) is strictly prohibited due to the theoretical potential for ergotism, a class-effect caution for macrolide antibiotics.
  • Additive Pharmacodynamic Risk: Caution is required with other QTc-prolonging drugs (e.g., Antiarrhythmics, certain Antipsychotics) due to an additive risk of QT prolongation and potentially serious cardiac arrhythmia.
  • Oral Anticoagulants: Concomitant use with Warfarin may potentiate its effect and increase coagulation times; the label requires careful monitoring of Prothrombin Time/INR.

Pharmacokinetic and Timing Rules

Interaction Type Interacting Substance Official Constraint Resulting Effect
Absorption Antacids (Aluminum/Magnesium) Must be administered at least 2 hours apart. Reduces the peak serum concentration (C max) of Azithromycin.
Transporter Effect Nelfinavir (P-gp Inhibitor) Requires close monitoring for Azithromycin adverse reactions. Significantly increases Azithromycin systemic exposure (AUC and C max).

Population Note: Caution is specifically advised for patients with severe renal impairment (GFR < 10 mL/min) and those with hepatic dysfunction, as these conditions can alter the drug's systemic exposure.

Mechanism of Action

Molecular Blockade of Bacterial Protein Synthesis

Cronopen's core mechanism is the inhibition of organism proliferation. Its active ingredient, Azithromycin, targets the 50S ribosomal subunit of susceptible prokaryotic cells. The drug physically binds to the 23S ribosomal RNA, which creates a blockade within the nascent peptide exit tunnel. This interaction inhibits the organism's protein synthesis pathway, specifically preventing the elongation of protein chains. The resulting bacteriostatic effect is the mechanism of arresting cellular growth and proliferation, which limits the organism's ability to propagate.

Secondary Modulation of Host Inflammatory Pathways

In addition to its direct anti-proliferative role, the drug engages a secondary mechanism by modulating signaling pathways in the host's immune cells. This involves reducing the production of key pro-inflammatory cytokines (e.g., IL-6, IL-8). This action alters host signaling, contributing to changes in localized mediator levels and affecting the overall physiological response to the organism's presence.

Constraints Imposed by Mechanistic Limitations

The overall action of Cronopen is limited by the organism's defense mechanisms. The mechanism is weakened if the organism acquires enzymes that modify the ribosomal binding site or if it actively develops efflux pumps that expel the drug from the cell before it can reach the 50S ribosomal target.

Dosage and Administration Information

The usage of Cronopen (Azithromycin) follows precise instructions. The primary route of administration is oral, available in tablets, capsules, or powder for suspension. An intravenous (IV) formulation is approved for the initial treatment of more severe conditions, requiring slow infusion over at least 60 minutes, and must not be given as a rapid bolus or intramuscular injection.

The dosage schedule is based on fixed-duration courses. The common 5-day regimen begins with a 500 mg dose on the first day, followed by 250 mg once daily on Days 2 through 5. Alternatively, a 3-day course utilizes 500 mg once daily for 3 days. Specific conditions may require a single dose of 1,000 mg or 2,000 mg. For long-term prophylaxis, such as for MAC, a 1,200 mg dose is taken once weekly.

Administration conditions depend on the formulation. Standard oral forms can be taken with or without food. However, the extended-release suspension must be taken on an empty stomach (1 hour before or 2 hours after a meal). Pediatric dosing is weight-based (mg/kg), requiring careful calculation, while older adults generally follow standard adult dosing. If a dose is missed, it should be taken as soon as possible, and the regular schedule resumed, avoiding the doubling of the next dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cronopen

This summary describes the evidence base for Cronopen (Azithromycin) as reported in official scientific and regulatory sources. It focuses on the nature of the research, what was studied, and what limitations are acknowledged in the data.


Evidence for Use in Acute Respiratory Infections: Sinusitis and Pneumonia

The evidence for Cronopen in conditions like acute bacterial sinusitis and community-acquired pneumonia relies primarily on short-term Randomized Controlled Trials (RCTs) and subsequent Meta-Analyses. These studies were conducted to compare the medicine against a placebo or against other specific study medications. The main focus of this research was to examine Clinical Cure Rates, used in research exploring how symptoms change over time, and Microbiological Eradication Rates, which monitored pathogen presence.

What remains uncertain is the persistence of patterns measured in these acute treatment outcomes. Research so far indicates that the follow-up durations were limited, providing few data on recurrence rates or the long-term impact on functional recovery following the acute illness.


Evidence for Use in Chronic Lung Conditions: COPD and Bronchiectasis

Research into Cronopen’s use for conditions characterized by fluctuating symptoms, such as chronic obstructive pulmonary disease (COPD) and bronchiectasis, involved distinct Long-Term Placebo-Controlled RCTs. These studies observed patients with a history of recurrent episodes of heightened symptom activity over significantly longer observation periods—often six months to over a year.

The primary focus of this research was on long-term outcomes, such as monitoring the Frequency of Acute Exacerbations and the time interval between them. Findings from these long-term studies consistently track the potential for developing bacterial resistance and also tracked specific findings, such as auditory changes, which was associated with prolonged administration.


What is Still Uncertain About Cronopen Research

The research landscape highlights several areas where certainty remains low or data are still emerging. A major area of uncertainty that is consistently tracked in the research is the long-term impact on antimicrobial resistance, which was associated with the prolonged or widespread use of the medicine. Research is ongoing to better characterize the true long-term outcomes and to clarify the findings for certain subgroups where the evidence quality varies across studies. The existing research provides context but not individual predictions.

Key Studies & References Azithromycin Drug Information: MedlinePlus - NIH

Frequently Asked Questions (FAQ)

Common questions about Cronopen (FAQ)

Q: Can I take Cronopen with common pain relievers like ibuprofen or acetaminophen?

Official drug labels list known and significant drug-drug interactions, such as those with blood thinners and certain heart rhythm medications. However, they do not specifically name or exclude common over-the-counter pain relievers like ibuprofen or acetaminophen. Patients are generally advised to discuss all medications they take, including pain relievers, with their healthcare provider or pharmacist.


Q: Why do some people take Cronopen for lung or respiratory infections?

Cronopen (Azithromycin) is indicated by regulatory authorities for the treatment of mild-to-moderate infections caused by susceptible bacteria. These approved uses include common respiratory conditions such as acute bacterial exacerbations of chronic bronchitis, acute bacterial sinusitis, and community-acquired pneumonia.


Q: Is Cronopen safe to take if I have a history of liver issues?

Official information states that Cronopen is contraindicated, meaning its use is restricted, in patients who have a prior history of cholestatic jaundice or hepatic (liver) dysfunction associated with previous Azithromycin use. Caution is also advised for patients with significant pre-existing liver disease. It is important that patients disclose their complete medical history, especially liver conditions, to their healthcare provider.


Q: Are there any long-term effects associated with using Cronopen?

Official labeling mentions important risks, including an increased short-term risk of cardiovascular death and the potential for a heart rhythm issue called QT interval prolongation. Specific long-term studies, primarily those involving chronic use in certain lung diseases, also tracked the potential for auditory changes and the risk of developing antimicrobial resistance over time.


Q: Can children safely be given Cronopen, and is the formulation different?

Cronopen is indicated for use in pediatric patients for certain bacterial infections, with specific dosages based on the child's weight. Safety and effectiveness, however, are not established in infants under six months of age. The medicine is available in various forms, including a powder for oral suspension (liquid), which is often used for children.


Q: What is the difference between Cronopen and other similar-sounding antibiotics?

The active ingredient in Cronopen, Azithromycin, is categorized as an azalide, which is a unique subclass of macrolide antibiotics. While it is chemically derived from erythromycin, its modified structure gives it distinct properties that differentiate it from other macrolides.


Q: Is it normal to feel a bit nauseous when first starting Cronopen?

Yes, regulatory documents list nausea as a very common gastrointestinal adverse reaction associated with the use of Cronopen (Azithromycin). Patients experiencing severe or persistent symptoms are encouraged to contact their healthcare provider.


Q: Are there any specific foods or drinks that should be avoided while on Cronopen?

While standard oral tablets can generally be taken with or without food, official warnings state that concomitant use with aluminum- or magnesium-containing antacids must be avoided or separated by at least two hours. This is to avoid reducing how much of the medicine the body absorbs.


Q: What should I do if I miss a dose of Cronopen?

According to official patient counseling information, if a dose is missed, it should be taken as soon as it is remembered. After taking the missed dose, the regular schedule should then be resumed. Official information states that patients should avoid doubling the next dose to compensate for a missed one.


Q: Does Cronopen cause yeast infections or thrush?

Regulatory documents list genitourinary adverse reactions that may include Monilia, a term associated with fungal or yeast infections like vaginitis (thrush). This is considered a less frequently reported side effect.


Q: What if I experience a strange metallic taste while taking Cronopen?

Official adverse reaction listings for Cronopen do not typically include a strange metallic taste (dysgeusia) among the most common effects. Any concerning symptoms should be discussed with a healthcare professional.


Q: Does Cronopen interact with blood pressure or heart medications?

Cronopen requires caution when taken with other medications known to affect the heart's electrical activity (specifically QTc-prolonging drugs). This is due to an added risk of serious cardiac rhythm abnormalities. Patients should ensure their healthcare team is aware of all current medications, especially those for blood pressure or heart conditions.


Q: What makes Cronopen effective against certain types of sexually transmitted infections?

Cronopen (Azithromycin) is indicated for treating certain sexually transmitted diseases, such as those caused by Chlamydia trachomatis. Its pharmacological properties allow it to achieve high concentrations in body tissues, including reproductive organs, contributing to its effectiveness in treating these specific infections.


Q: Can Cronopen be prescribed for skin or soft tissue infections?

Yes, official indications confirm that Cronopen (Azithromycin) is approved for the treatment of mild-to-moderate uncomplicated infections of the skin and skin structure caused by susceptible bacteria.


Q: Is there a risk of developing antibiotic resistance with Cronopen use?

Yes, official warnings state that prescribing Cronopen in the absence of a proven or strongly suspected bacterial infection increases the risk of the development of drug-resistant bacteria. Therefore, it is intended only for use against bacterial infections.


Q: Are there different brand names or generic versions of the active ingredient in Cronopen?

Yes, the active ingredient in Cronopen is Azithromycin. This active compound is available under various brand names (like Zithromax and Zmax) as well as numerous generic versions, depending on the country and manufacturer.


Q: How do the ingredients in Cronopen work together to treat bacterial infections?

Cronopen is a single-ingredient product containing only the active compound Azithromycin. This compound works by directly targeting the bacteria's ability to create necessary proteins, effectively halting their growth and replication.


Q: Can Cronopen cause changes in mood or sleep patterns?

Less frequently reported side effects listed in official documents include effects on the nervous system such as dizziness, headache, and vertigo. Changes to mood or sleep patterns are not typically listed among the common adverse reactions, but any concerning symptoms are best discussed with a healthcare provider.


Q: What kind of infections are not treated by Cronopen?

Cronopen is an antibiotic and, as stated in regulatory limitations, it is not effective against infections caused by viruses, such as the common cold or flu. It is intended only for use when a bacterial infection is proven or strongly suspected.


Q: Are there any specific warnings for people with kidney disease taking Cronopen?

Official warnings advise caution for patients with severe renal impairment (a Glomerular Filtration Rate or GFR of less than 10 mL/min). This is because these individuals may experience increased systemic exposure to the drug.


Q: Is Cronopen used for long-term or maintenance therapy in some chronic conditions?

Yes, Cronopen is indicated for the prevention of disseminated Mycobacterium avium Complex (MAC) disease in certain patients. For this use, the treatment involves a maintenance dose taken once a week.

How should Cronopen be stored and disposed of?

Storage Requirements

Cronopen (Azithromycin) must be stored according to regulatory specifications to maintain its stability.

Product Form Storage Temperature Stability/Handling Rules
Tablets/Capsules Controlled Room Temperature (15 C to 30 C) Protect from heat, moisture, and light. Do not freeze.
Powder (Unmixed) Below 30 C (86 F) Store in a closed container, away from excess heat.
Oral Suspension (Mixed) Room temperature or refrigerated (5 C to 30 C) Discard any unused product after 10 days of preparation. Do not freeze.

All forms of the medicine must be kept out of the sight and reach of children.

Disposal Instructions

Regulatory agencies require specific disposal procedures for Cronopen. Unused liquid suspension must be discarded immediately after the treatment course is finished. As Azithromycin is not on the FDA's flush list, unused solid forms should be disposed of by mixing them with an undesirable substance (such as coffee grounds or dirt), sealing the mixture in a bag, and discarding it in the household trash, or by using an official take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cronopen found in:

A-Z Index: